Welcome to our dedicated page for Bowen Acquisition SEC filings (Ticker: BOWN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bowen Acquisition Corp filings document its SPAC structure and public-company reporting obligations, including notices of late Form 10-K and Form 10-Q filings, material-event reports, shareholder voting matters, governance disclosures and capital-structure updates.
As a blank-check issuer, the company’s regulatory record centers on unit, warrant and rights terms, trust-account and redemption mechanics, shareholder approvals, and other disclosures tied to maintaining its capital structure and corporate status while pursuing a business combination.
Bowen Acquisition Corp (BOWN) calls a shareholder vote to extend its SPAC deadline. The extraordinary general meeting is set for 10:00 a.m. ET on December 12, 2025, to approve an amendment allowing up to six one‑month extensions, moving the current termination date from December 14, 2025 to as late as June 14, 2026. A separate proposal would permit adjournment if more time is needed to effect the extension.
Public shareholders may elect to redeem their shares for cash from the trust by submitting shares to the transfer agent by 5:00 p.m. ET on December 10, 2025. The company notes shareholders had already approved its business combination with Shenzhen Qianzhi BioTechnology in January 2025, but closing remains pending. If the extension fails and no deal closes by December 14, 2025, Bowen will redeem public shares and liquidate per its charter.
As of the record date November 12, 2025, 2,994,371 ordinary shares were outstanding, including 727,871 public shares. Sponsors and insiders hold 2,066,782 shares (approximately 69%) and intend to vote in favor.
Bowen Acquisition Corp. (BOWN) reported a Nasdaq delisting decision. Nasdaq notified the company on July 11, 2025 that it was not compliant with Listing Rule 5450(a)(2) requiring at least 400 total shareholders. On July 15, 2025, Nasdaq issued a delisting determination and halted trading, citing additional deficiencies, including Market Value of Listed Securities of at least $50,000,000 for 30 consecutive trading days, a minimum of 1,100,000 publicly held shares, and Market Value of Publicly Held Shares of at least $15,000,000 for 30 consecutive trading days.
After an appeal and hearing on August 21, 2025, a Panel allowed continued listing if the company completed its business combination by October 15, 2025. On October 30, 2025, Nasdaq determined to delist the securities at the open on November 3, 2025 because the combination was not completed by the deadline. Bowen has requested review by the Nasdaq Listing and Hearing Review Council; there is no assurance of continued listing or a stay.